Location: Central, Hong Kong, Hong Kong
CIK: 0001668029 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value: $5.82M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ABG ACQUISITION CORP I | 501,300 | $4.883M | 83.9% | $9.89 | — | CL A SHS | G00496102 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $891K | 15.3% | $7.87 | — | COM | 00773J103 |
| — | DIFFUSION PHARMACEUTICALS IN | 89,848 | $46,000 | 0.8% | $0.79 | — | COM PAR | 253748305 |